Covered recipient · General Payments record
JYOTI BHAT
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$6,089.38
- Reported across 274 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,413.59 | 67 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $306.38 | 18 |
| Lilly USA, LLC | $102.37 | 7 |
| Exact Sciences Corporation | $83.44 | 3 |
| SANOFI-AVENTIS U.S. LLC | $80.18 | 3 |
| Alexion Pharmaceuticals, Inc. | $60.82 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $58.41 | 3 |
| Ascendis Pharma Endocrinology Inc | $58.12 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $51.68 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $49.64 | 3 |
| Madrigal Pharmaceuticals | $46.76 | 3 |
| Novo Nordisk AS | $46.03 | 2 |
| Neurocrine BioSciences, Inc. | $44.89 | 2 |
| Astellas Pharma US Inc | $41.36 | 2 |
| Fresenius Kabi USA, LLC | $34.82 | 1 |
| Radius Health, Inc. | $32.06 | 1 |
| BETA BIONICS, INC. | $31.54 | 1 |
| Globus Medical, Inc. | $31.42 | 1 |
| DEXCOM, INC. | $30.37 | 1 |
| Averitas Pharma Inc. | $29.34 | 1 |
| Esperion Therapeutics, Inc. | $28.72 | 1 |
| ARS Pharmaceuticals Operations, Inc. | $23.96 | 1 |
| Abbott Laboratories | $23.78 | 1 |
| GlaxoSmithKline, LLC. | $23.37 | 1 |
| Genentech USA, Inc. | $22.60 | 1 |
| Xeris Pharmaceuticals, Inc. | $21.36 | 1 |
| Organon LLC | $18.90 | 1 |
| Medtronic, Inc. | $16.59 | 1 |
| Antares Pharma, Inc. | $14.68 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (67)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.